000			01508 a2200409 4500
005			20250513230900.0
264		0	_c20010308
008			200103s 0 0 eng d
022			_a0015-0282
024	7		_a10.1016/s0015-0282(00)01691-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aCardim, H J
245	0	0	_aThe insulin-like growth factor-I system and hormone replacement therapy. _h[electronic resource]
260			_bFertility and sterility _cFeb 2001
300			_a282-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdministration, Cutaneous
650	0	4	_aAdministration, Oral
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aEstrogen Replacement Therapy _xadverse effects
650	0	4	_aEstrogens _xadministration & dosage
650	0	4	_aEstrogens, Conjugated (USP) _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin-Like Growth Factor Binding Protein 1 _xblood
650	0	4	_aInsulin-Like Growth Factor Binding Protein 3 _xblood
650	0	4	_aInsulin-Like Growth Factor I _xanalysis
650	0	4	_aNorethindrone _xadministration & dosage
650	0	4	_aPostmenopause
700	1		_aLopes, C M
700	1		_aGiannella-Neto, D
700	1		_ada Fonseca, A M
700	1		_aPinotti, J A
773	0		_tFertility and sterility _gvol. 75 _gno. 2 _gp. 282-7
856	4	0	_uhttps://doi.org/10.1016/s0015-0282(00)01691-5 _zAvailable from publisher's website
999			_c11111684 _d11111684